Compare SQM & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SQM | PEN |
|---|---|---|
| Founded | 1968 | 2004 |
| Country | Chile | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6B | 10.9B |
| IPO Year | 1993 | 2015 |
| Metric | SQM | PEN |
|---|---|---|
| Price | $61.39 | $299.66 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 16 |
| Target Price | $50.81 | ★ $307.19 |
| AVG Volume (30 Days) | ★ 2.1M | 479.9K |
| Earning Date | 11-18-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.45% | N/A |
| EPS Growth | N/A | ★ 367.34 |
| EPS | 1.84 | ★ 4.14 |
| Revenue | ★ $4,326,111,000.00 | $1,333,798,000.00 |
| Revenue This Year | N/A | $16.77 |
| Revenue Next Year | $22.11 | $14.12 |
| P/E Ratio | ★ $33.36 | $72.65 |
| Revenue Growth | N/A | ★ 14.61 |
| 52 Week Low | $29.36 | $221.26 |
| 52 Week High | $65.65 | $310.00 |
| Indicator | SQM | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 61.38 | 67.77 |
| Support Level | $59.97 | $284.95 |
| Resistance Level | $65.65 | $298.69 |
| Average True Range (ATR) | 2.39 | 8.02 |
| MACD | -0.26 | 0.11 |
| Stochastic Oscillator | 48.65 | 91.50 |
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.